Trials
Search / Trial NCT06421363

Continuity of Care Between Primary Care Cardiology and Specialty Services for Patients With Chronic Ischemic Heart Disease

Launched by JOSE SEIJAS AMIGO · May 14, 2024

Trial Information

Current as of February 08, 2025

Not yet recruiting

Keywords

Inclisiran

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age ≥18 years
  • 2. Prior diagnosis of chronic coronary disease
  • At least one of the following:
  • 1. Type 2 diabetes mellitus
  • 2. Familial hypercholesterolemia
  • 3. Recurrent coronary disease
  • 4. Chronic kidney disease
  • 3. Currently undergoing pharmacological treatment with high-potency statins, with or without ezetimibe. The allowed statins and daily doses are:
  • 1. Atorvastatin 80mg
  • 2. Rosuvastatin 20mg
  • 3. Rosuvastatin 40mg
  • 4. Patients on other statins or lower doses are acceptable if there has been documented intolerance to the specified molecules and doses.
  • 4. Blood analysis with a lipid profile in the last 6 months and with the current treatment showing LDL levels \>100mg/dl.
  • Exclusion Criteria:
  • 1. Not receiving statins in the therapeutic regimen.
  • 2. Concomitant treatment with PCSK9 inhibitors.
  • 3. Pregnancy, breastfeeding, or a desire to conceive by the patient.
  • 4. Patients who, in the opinion of the investigator, are unable to adequately follow up in the chronic care program under routine clinical practice.

About Jose Seijas Amigo

Jose Seijas Amigo is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on rigorous scientific standards and ethical practices, the organization collaborates with healthcare professionals, researchers, and regulatory bodies to facilitate the development of new therapies and treatment modalities. By prioritizing patient safety and regulatory compliance, Jose Seijas Amigo aims to contribute significantly to the medical community and improve patient outcomes through well-designed clinical trials.

Locations

Ribeira, A Coruña, Spain

A Estrada, A Coruña, Spain

Ames, A Coruña, Spain

Santiago De Compostela, A Coruña, Spain

Melide, , Spain

Pontevedra, , Spain

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0